Page last updated: 2024-11-04

terfenadine and Chronic Kidney Diseases

terfenadine has been researched along with Chronic Kidney Diseases in 2 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Research Excerpts

ExcerptRelevanceReference
"Midazolam AUC was significantly higher in the HD group (382."1.42Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms. ( Asher, LJ; Feere, DA; House, AA; Knauer, MJ; Nolin, TD; Thomson, BK; Urquhart, BL; Velenosi, TJ, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joy, MS1
Frye, RF1
Nolin, TD2
Roberts, BV1
La, MK1
Wang, J1
Brouwer, KL1
Dooley, MA1
Falk, RJ1
Thomson, BK1
Velenosi, TJ1
Feere, DA1
Knauer, MJ1
Asher, LJ1
House, AA1
Urquhart, BL1

Trials

1 trial available for terfenadine and Chronic Kidney Diseases

ArticleYear
In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases.
    Pharmacotherapy, 2014, Volume: 34, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Breath Tests; Case-Control Studies; Cytochrome

2014

Other Studies

1 other study available for terfenadine and Chronic Kidney Diseases

ArticleYear
Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 65, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Anti-Anxiety Agents; Cytochrome P-450 CYP3A; F

2015